DOCSLIB.ORG

ATS Problems in Southeast Asia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ATS Problems in Southeast Asia Amphetamine Type Stimulants problems Especially in South-East Asia • Global and Asian Trends • Short and long-term effects • Treatment of Stimulant Use disorder • Methamphetamine treatment system in Thailand • Dr. Apinun Aramrattana • Southeast Asia HIV Addiction Technology Transfer Center • Dept. of Family Medicine, Faculty of Medicine, Chiang Mai University, Thailand Expanding market: Amphetamine-type stimulants (ATS) ATS seized worldwide • Total ATS seizures: highest ever • Amphetamine and methamphetamine constitute considerable share of burden of disease, rank second only after opioids • Users of amphetamines increased, reaching 37 million globally • Methamphetamine seizures up, East and South-East Asia overtaking North America • “Ecstasy” seizures stable but greater variety of products on the market Rapid methamphetamine pill epidemics in Thailand DRUG TREATMENT STATISTICS 0.4 0.6 1.1 1 1.7 2.6 NUMBER 100% 10.6 12.8 7.7 5.3 19.3 16.5 13.8 34.1 80% 5.3 53.7 57.4 60% 60.3 6.3 Thai Act 1996:83.4 84.9 40% 73.7 78.2 76 71.1Amp./meth.72.5 moved to Sch.I 5.7 6.6 6 47.8 20% 32.1 24.1 19.6 0% 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Heroin Opium Ganja Inhalant Alcohol ATS Others Source: Dept. of Medical Services, MOPH and Institute of Health Research,C U., ONCB V.Poshyachinda - Methamphetamine 15-20 % + Caffeine 50-65% Household Survey Trends: Ever users: 2001-2016 War on Drugs since 2003 Estimated Numbers ( x 1,000) Source: ACSAN, ONCB, 2012 Methamphetamine tablets(Ya Ba), Marihuana, and Kratom are the most common drugs used with Ice epidemics emerging. Source: The Office of Narcotic Control Board (ONCB) Level of risk by ASSIST scores Household Survey, Thailand, 2011 Substance types Estimation %L %M %S Alcohol 27,907,999 76.8 20.3 2.9 Smoking 13,905,217 33.8 62.5 3.7 Marihuana 2,064,386 94.5 5.2 0.3 Methamphetamines 910,361 88.0 11.1 0.9 Benzodiazepine 885,559 84.5 14.1 1.4 Opiates 475,557 98.0 2.0 - Inhalants 200,407 92.9 7.1 - Majority of substance users were in low risk except smoking. Estimated number of ATS users in Thailand, 2011: 910,361 Risk levels ASSIST Scores High 1 % >26 Moderate 11 % 4-26 Low 88 % 0-3 WHO-ASSIST Score among ATS ever users, Household Survey, 2011. Only about 12 % of MA ‘ever’-users would need treatment. Source: The Office of Narcotic Control Board (ONCB) Admission by major drug type Methamphetamine, heroin and cannabis prevalence (/100,000 pop.) Assoc.Prof. Manop Kanato @ASEAN Narco Khon Kaen University, Thailand & ONCB, Thailand Assoc.Prof. Manop Kanato @ASEAN Narco Khon Kaen University, Thailand & ONCB, Thailand Understand young ATS users:- Age at first use of methamphetamine • Majority were 40 young males 91% • 99% Inhalation / 30 take orally 20 • Multiple sex Percent partners 10 • Age of first sex 0 9 10 11 12 13 14 15 16 17 18 19 20 21 around 13-14 Age years Celentano D D, Aramrattana A, Sutcliffe CG, et.al. (2008) Journal of Adolescent Medicine. 2(2):66-73. Crystal Meth Chemically similar to amphetamines White, odourless, bitter-tasting crystalline powder Route: oral, smoked, snorted, or injected Made in illegal labs by chemically altering OTC medicines (pseudoephedrine) Ecstasy • Stimulant and hallucinogen properties • First synthesized by the German pharmaceutical company Merck in 1912. • Tested by the military in search for the “truth drugs” 1953 • Made in illicit labs and may contain other active such as amphetamine, mephedrone, methamphetamine, ephedrine, or caffeine • Some tablets sold as ecstasy do not even contain any MDMA • Street names include “E” , “X”, Molly, Skittles Prescription Stimulants Methylphenidate (Ritalin, Concerta, Biphentin) Dextroamphetamine Sulphate (Dexedrine) Amphetamine and Dextroamphetamine (Adderall) Lisdexamfetamine (Vyvanse) The Brain in Stimulant Use Disorders Methamphetamines Inhibit reuptake of synaptic dopamine AND promotes direct dopamine release Ecstasy: Acutely increases serotonin by blocking reuptake and directly releasing Chronically decreases serotonin levels by depleting serotonin stores and inhibiting the synthesis of new serotonin neurotoxicity Pharmacology of Stimulants Water soluble Onset of action depends on route of administration: rapid onset of action with injection or smoking Duration of action dependent on route of administration: oral administration produces longer duration of action Short-term Effects • Increased attention and decreased fatigue • Increased activity and wakefulness • Decreased appetite • Euphoria and rush • Increased respiration • Rapid/irregular heartbeat • Hyperthermia • A distorted sense of well-being • Effects that can last 8 to 24 hours NIDA, 2006. 15 Stimulant Intoxication Signs or Symptoms 1. Tachycardia or bradycardia 2. Pupillary dilation 3. Elevated or lowered blood pressure 4. Perspiration or chills 5. Nausea or vomiting 6. Evidence of weight loss 7. Psychomotor agitation or retardation 8. Muscular weakness, respiratory depression, chest pain, or cardiac arrhythmias 9. Confusion, seizures, dyskinesias, dystonias, or coma Stimulant Intoxication Clinically significant problematic behavioural or psychological changes such as: euphoria or affective blunting changes in sociability hypervigilance interpersonal sensitivity anxiety tension or anger stereotyped behaviours impaired judgement Stimulant Withdrawal Dysphoric mood and two (or more) of the following physiological changes, developing within hours to several days after cessation of prolonged amphetamine-type substance, cocaine or other stimulant use 1. Fatigue 2. Vivid, unpleasant dreams 3. Insomnia or hypersomnia 4. Increased appetite 5. Psychomotor retardation, or agitation DSM 5 Acute Consequences of Stimulant Use Neuro: seizures, strokes CVS: tachycardia, arrythmia, MI, HTN Kidneys: cocaine induced rhabdomyolysis Heme: Agranulocytosis (levamisole) Repro: placenta previa ENT: nosebleeds Infectious Disease: STI’s, cellulitis, bacterial endocarditis ECSTASY: Dehydration, Hyperthermia, Hyponatremia Stimulant Induced Mental Health Disorders INTOXICATION WITHDRAWAL Psychotic Delusions Bipolar Bipolar Depression Depression Anxiety Anxiety OCD OCD Sleep Disorders Sleep Disorders Sexual Dysfunction Long Term Consequences of Stimulant Use Tolerance and Withdrawal Sensitization Addiction (Stimulant Use Disorder) Restlessness, anxiety, irritability, paranoia, panic attacks, mood disturbances Insomnia Sensitization Sensitization (opposite of tolerance) more you use the drugs more likely of symptoms happening such as: Seizure Psychosis (paranoia, visual, auditory, and tactile hallucinations) Stereotypical behaviors Long Term Consequences of Stimulant Use Repro: irregular menses, prematurity ENT: nasal septum perforation, loss of sense of smell, chronically runny nose Infectious Disease: Hep C, HIV Weight loss Methamphetamines (neurocognitive impairment, “meth mouth”) Psychosocial: homelessness, legal involvement, trauma Harms: Duration of amphetamine use (yrs) and frequency alcohol use in last 30 days) among MA users in Chiang Mai, Thailand, 2005 High prevalence of depression Male = 31% P < .0001 Female = 45% Longer duration of MA use led to heavier drinking patterns and higher depression prevalence. Celentano D D, Aramrattana A, Sutcliffe CG, et.al. (2008) Journal of Adolescent Medicine. 2(2):66-73. Harms: Prevalence rates Sexually Transmitted Infections, methamphetamine users, 2005 50 Less than 50% seek treatment 40 from any health services. 30 29.4 20 Percentpositive 18.5 10 7.7 5.5 0 Male Female Ref. Male Female Ref. Chlamydia trachomatis Neisseria gonorrhea High Sexually Transmitted Infection especially among female MA users. Celentano D, Sirirojn B, Sutcliffe C, et.al. (2008) Sexually Transmitted Diseases 35,400-5. Long-term study among MA Psychotic Patients at Suan Prung Psychiatric Hospital 2001-2007 Number of Patients War on drugs Rehabilitation law 4500 4000 3500 3000 2500 2000 1500 1000 500 0 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 Years Long-term effects from MA psychosis. 8.2% mortality in 6 years among MA psychotic patients. Main causes were suicide, accidents & AIDS Source: Kittiratanapaiboon, P. et.al., Drug Alcohol Rev. 2010 Jul;29(4):456-61 10-year trends of methamphetamine injection in Thailand, treatment statistics 2008-2017 • In general, methamphetamine injection of any forms were less than 1%. • Increasing trends of Ice injection (especially among MSM/TG) Source: Thai Office of Narcotic Control Board, unpublished data, July 2018 TREATMENT OF STIMULANT INTOXICATION, STIMULANT WITHDRAWAL, AND STIMULANT USE DISORDER Treatment of Stimulant Intoxication Supportive Phentolamine for hypertension (no beta blockers bc unopposed alpha-adrenergic stimulation can lead to coronary vasoconstriction and ischemia) Chest pain: ECG, biomarkers, CXR, benzo and nitro Treat stimulant induced psychosis if severe Treat any infections: cellulitis, endocarditis, infectious diseases (HIV, Hep C, STI’s), abscesses, septic arthritis Treatment of Stimulant Withdrawal Supportive Suicide prevention Treatment of Stimulant Use Disorders SBIRT (Screening, Brief Intervention, Referral to Treatment) Stages of Change Harm Reduction (needle exchange/crack pipe programs) Motivational Enhancement Therapy Cognitive Behavioural Therapy Contingency Management Residential Treatment Self Help Support Matrix Model Treatment of Underlying Mental Health Disorders Treat any Medical Complications (HIV, HCV) Risk of Relapse Re-exposure to the Drug Exposure to stress Exposure to environmental cues Conditioned response to drug-related
Load more

Recommended publications
  • 1. CAMBODIA 1.1 General Situation 1.1.1 Drug Use There Are No
    COUNCIL OF Brussels, 15 April 2014 THE EUROPEAN UNION (OR. en) 8990/14 CORDROGUE 26 ASIE 22 NOTE From: Japanese Regional Chair of the Dublin Group To: Dublin Group No. prev. doc.: 14715/13 Subject: Regional Report on South East Asia and China 1. CAMBODIA 1.1 General situation 1.1.1 Drug use There are no consistent statistics as to the exact number of people who use drugs in Cambodia. However the general consensus among the Royal Government of Cambodia and international agencies is that there are currently between 12,000 and 28,000 people who use drugs. Methamphetamine pills are the most widely used drug in Cambodia, although crystalline methamphetamine is becoming more widely available, with use on the rise, particularly in Phnom Penh and among unemployed youth. Whereas illicit drug use was previously concentrated primarily in urban settings, in recent years it has been expanding into rural areas, in particular in the provinces adjacent to Lao PDR and Thailand (INCSR Cambodia 2012). Drug use among women and within prisons appears to be on the rise (UNODC 2013). 8990/14 JV/fm 1 DG D 2C EN Table 1. Rank of primary drugs of concern in Cambodia, 2008-2012 Drug type 2008 2009 2010** 2011*** 2012**** Methamphetamine pills ● 2* 1 2 2 Crystalline methamphetamine ● 1* 2 1 1 Ecstasy ● ● ● 6 ● Cannabis ● ● 4 4 4 Heroin ● ● 3 5 ● Inhalants ● ● ● 3 3 Opium ● ● ● ● ● ● = Not reported Source(s): *NACD 2010a. **2010 rankings based on DAINAP data and Cambodia country reports. ***NACD 2012b. ****2012 rankings are based on data provided by the National Authority for Combating Drugs.
    [Show full text]
  • Methamphetamine Use: Lessons Learned
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Methamphetamine Use: Lessons Learned Author(s): Dana Hunt, Ph.D.; Sarah Kuck; Linda Truitt, Ph.D. Document No.: 209730 Date Received: February 2006 Award Number: 99-C-008 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. ANALYTIC SUPPORT PROGRAM CONTRACT TASK REQUIREMENT T-043: Methamphetamine Use: Lessons Learned Contract No. 99-C-008 Cambridge, MA Lexington, MA Hadley, MA Bethesda, MD Chicago, IL January 31, 2006 Prepared for Raymond C. German Contracting Officer Christine Crossland Senior Social Science Analyst National Institute of Justice Office of Justice Programs Acquisition Management Division 810 Seventh Street, SW Washington, D.C. 20001 Prepared by Dana Hunt, Ph.D. Sarah Kuck Abt Associates Inc. Linda Truitt, Ph.D. 55 Wheeler Street Cambridge, MA 02138 Contents Executive Summary...............................................................................................................iii History of Methamphetamine Use .................................................................................iii Trends.............................................................................................................................iii
    [Show full text]
  • National Drug Threat Assessment 2002
    National Drug Intelligence Center U.S. Department of Justice U.S. Department of Justice National Drug Intelligence Center Product No. 2002-Q0317-001 December 2001 National Drug Threat Assessment 2002 National Drug Intelligence Center 319 Washington Street, 5th Floor Johnstown, PA 15901-1622 (814) 532-4601 National Drug Threat Assessment 2002 From the Director: I am pleased to present the National Drug Threat Assessment 2002, the culmination of dedicated work by the National Drug Intelligence Center in partnership with federal, state, and local agencies and organizations. In accordance with the provisions of the General Counterdrug Intelligence Plan, the National Drug Threat Assessment integrates foreign and domestic counterdrug intelligence and information on domestic drug consumption trends in a single report. This report is a comprehensive assessment of the threat posed to our society by illicit drugs. It integrates the most recently available reporting from national-level law enforcement, intelligence, and health and human service agencies including the Drug Enforcement Administration, Federal Bureau of Investigation, U.S. Coast Guard, U.S. Customs Service, El Paso Intelligence Center, Financial Crimes Enforcement Network, Crime and Narcotics Center, National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration, and National Institute of Justice. It incorporates data from current national drug abuse indicators—Arrestee Drug Abuse Monitoring Program, Drug Abuse Warning Network, Monitoring the Future Study, National Household Survey on Drug Abuse, Parents’ Resource Institute on Drug Education Survey, and Treatment Episode Data Set—to accurately and reliably depict the current domestic drug abuse situation. The National Drug Threat Assessment draws on information provided by nearly 2,600 state and local law enforcement agencies throughout the country to document the current threat and emerging trends in drug trafficking and related criminal activity in the United States.
    [Show full text]
  • (ATS) Production and Trafficking in Southeast Asia Countries
    Risalah HUKUM Fakultas Hukum Unmul, Juni 2010, Hal. 53 - 62 Vol. 6, No. 1 ISSN 021-969X Amphetamines Type Stimulant (ATS) Production and Trafficking In Southeast Asia Countries Milda Istiqomah Fakultas Hukum Universitas Brawijaya Jl.MT.Haryono Nomor 169 Malang 65145 e-mail:[email protected] ABSTRACT This article addresses the pattern of Amphetamines Type Stimulants (ATS) production and trafficking in Southeast Asia countries. The objective of this article is to investigate organizational form and trafficking network of ATS within the region. Indonesia, Myanmar, and Cambodia will be used as analyzing case of the largest amphetamine producing and trafficking centre in the territory. The poverty, geo-strategic location, unstable sociopolitical situation and systemic corruption in law enforcement agencies are identified as the root of the emergence of multifaceted and transnational drugs trafficking in Southeast Asia. This article also provides suggestion on how to circumvent the impediments faced by the governments. Key words: amphetamines type stimulants and trafficking Introduction countries are responsible for contributing the Southeast Asia countries are facing a illicit drugs trafficking within the world. Several serious threat of their security from drugs countries within this region are posing as trafficking recently. The golden triangle producing, supplying and transiting point of countries consisting of Burma, Thailand and illicit drugs. Laos are pointed as the world’s second largest Gary Reid et al address a report of opium producer and supplier in the Asia Pacific drug production, trafficking and trade in Asia region. Amphetamines productions are also and Pacific Island countries. 1 They estimate found throughout most of the Southeast Asia that Myanmar is the largest producer of opium region, in particular Indonesia, Myanmar and around “370 metric tones” in the Asia region, Cambodia.
    [Show full text]
  • Drug Enforcement Administration's International Operations
    REDACTED – PUBLIC VERSION THE DRUG ENFORCEMENT ADMINISTRATION’S INTERNATIONAL OPERATIONS U.S. DEPARTMENT OF JUSTICE OFFICE OF THE INSPECTOR GENERAL AUDIT DIVISION AUDIT REPORT 07-19 FEBRUARY 2007 REDACTED – PUBLIC VERSION REDACTED – PUBLIC VERSION THE DRUG ENFORCEMENT ADMINISTRATION’S INTERNATIONAL OPERATIONS* EXECUTIVE SUMMARY The Drug Enforcement Administration (DEA) is the primary federal agency responsible for investigating illicit drug trafficking organizations operating within the United States. The ultimate goal of the DEA’s efforts is to significantly disrupt drug trafficking operations and to dismantle the criminal organizations entirely, while ultimately bringing their leaders to prosecution, either in the United States or through another country’s judicial system. In order to combat the highest priority drug trafficking organizations, the DEA must extend its operations to other countries where major drug traffickers live and preside over illegal operations. As a result, the DEA has 751 employees in 59 other countries who work with foreign law enforcement agencies, as well as with other U.S. agencies operating in the international arena, to accomplish its mission.1 To support its personnel and operations abroad, in fiscal year (FY) 2006 the DEA had a budget of $312 million for its international operations. The Department of Justice (DOJ), Office of the Inspector General (OIG) conducted this audit of the DEA’s international operations. The objectives of the audit were to: (1) review the DEA’s foreign office performance, including
    [Show full text]
  • Methamphetamine Use Among Thai Women: a Qualitative
    METHAMPHETAMINE USE AMONG THAI WOMEN: A QUALITATIVE STUDY AT THANYARAK INSTITUTE By Sarun Gorsanan A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree DOCTOR OF PHILOSOPHY Program of Social and Administrative Pharmacy Graduate School SILPAKORN UNIVERSITY 2006 การใชเมทแอมเฟตามีนในสตรีไทย : การวิจัยเชิงคุณภาพในสถาบันธัญญารักษ โดย นายศรัณย กอสนาน วิทยานิพนธน ี้เปนสวนหนงของการศึ่ ึกษาตามหลกสั ูตรปริญญาเภสัชศาสตรดุษฎีบัณฑิต สาขาวิชาเภสชศาสตรั สังคมและการบริหาร บัณฑิตวทยาลิ ัย มหาวิทยาลัยศิลปากร ปการศึกษา 2549 ลิขสิทธิ์ของบณฑั ิตวิทยาลยั มหาวิทยาลยศั ิลปากร The graduate school, Silpakorn University accepted thesis entitled “METHAMPHETAMINE USE AMONG THAI WOMEN: A QUALITATIVE STUDY AT THANYARAK INSTITUTE” by Sarun Gorsanan in partial fulfillment of the requirements for the degree of Doctor of Philosophy, Program of Social and Administrative Pharmacy. …………………………………………….. (Assoc.Prof. Sirichai Chinatankul, Ph.D.) Dean of Graduate School ……….../…………/…………… Thesis advisors 1. Pagamas Maitreemit, Ph.D. 2. Assoc.Prof. Chuthamanee Suthisisang, Ph.D. 3. Assoc.Prof. Luechai Sringernyuang, Ph.D. Thesis committee …………………………….. Chairman …………………………….. Member (Assist. Prof. Burin T. Sriwong, Ph.D.) (Prof. Chomchin Chantaraskul, Ph.D.) ……….../…………/…………… ……….../…………/…………… …………………………….. Member …………………………….. Member (Pagamas Maitreemit, Ph.D.) (Assoc.Prof. Chuthamanee Suthisisang, Ph.D.) ……….../…………/…………… ……….../…………/…………… …………………………….. Member (Assoc.Prof. Luechai Sringernyuang, Ph.D.) ……….../…………/…………… 45354901: MAJOR: SOCIAL AND ADMINISTRATIVE
    [Show full text]
  • Myanmar/Burma 1. General Situation 1.1 Opium and Opiates
    Council of the European Union Brussels, 13 April 2015 (OR. en) 7849/15 CORDROGUE 21 ASIE 13 NOTE From: Australian Regional Chair of the Dublin Group To: Delegations No. prev. doc.: 14832/14 CORDROGUE 81 ASIE 66 Subject: Regional Report on South East Asia and China Myanmar/Burma 1. General Situation 1.1 Opium and opiates Myanmar is considered to be the second largest producer of opium in the world, behind Afghanistan. East Asia illicit opiate industry value is estimated at $16.3 billion per year, the majority of which is driven from Myanmar opium/heroin. In 1999 the Myanmar Government and local authorities engaged in a 15-year plan to eliminate opium poppy cultivation by 2014. This Plan has now been extended a further five years and will conclude in 2019. Until 2006 there was a considerable decrease in the total area under opium poppy cultivation in Myanmar, as a result of efforts to eradicate opium poppy cultivation as well as the imposition by local authorities of an opium ban in the Wa region in June 2005 and in the Kokang Special Region in 2003. 7849/15 JV/np 1 DG D 2C EN However, illicit opium poppy cultivation has since increased although it is still well below the levels reached in the 1990s. After reaching a minimum level in 2006, opium cultivation began to gradually increase again in 2007. According to the UNODC Opium Poppy Survey report1 on Myanmar, poppy cultivation in Myanmar rose 13% from the previous year to 57,800 hectares, more than doubling since 2006.
    [Show full text]
  • The United Wa State Army and Burma's Peace Process
    The United Wa State Army and Burma’s Peace Process By Bertil Lintner NO. 147 | APRIL 2019 Making Peace Possible NO. 147 | APRIL 2019 ABOUT THE REPORT Supported by USIP’s Asia Center to provide policymakers and the general public with a better understanding of Burma’s ethnic conflicts, this report examines the role of PEACE PROCESSES both the United Wa State Army and China in Burma’s peace process and suggests ways forward to break the present stalemate. ABOUT THE AUTHOR Bertil Lintner has covered Burma’s civil war and related issues such as narcotics trafficking for more than thirty-five years. Burma correspondent for the Far Eastern Economic Review from 1982 to 2004, he now writes for Asia Times and is the author of several books about Burma’s civil war and ethnic strife. Cover photo: United Wa State Army soldiers march during a media display in Panghsang, in the Wa Self-Administered Division of Shan State, Burma. (Photo by Soe Zeya Tun/Reuters) The views expressed in this report are those of the author alone. They do not necessarily reflect the views of the United States Institute of Peace. An online edition of this and related reports can be found on our website (www.usip.org), together with additional information on the subject. © 2019 by the United States Institute of Peace United States Institute of Peace 2301 Constitution Avenue NW Washington, DC 20037 Phone: 202.457.1700 Fax: 202.429.6063 E-mail: [email protected] Web: www.usip.org Peaceworks No. 147. First published 2019. ISBN: 978-1-60127-765-7 Making Peace Possible Contents 3 Introduction 4 Who Are the Wa? 6 Communism 10 Drug Trafficking 13 The UWSP, UWSA, and Their Allies 16 The UWSP and China’s Role in the Peace Process 22 Conclusion and Policy Recommendations USIP.ORG 1 Summary The United Wa State Army (UWSA), with its twenty-odd thousand men in arms, is the largest of Burma’s ethnic armed organizations (EAOs).
    [Show full text]
  • Submission to the Committee's Inquiry Into Amphetamine and Other Synthetic Drugs and to Subsequent Telephone Conversations Between Your Office and Mr Bush
    nd Friendsfor DrugLaw Reform(ACT) Inc. tragedythat arisesfrom illicit drug use POBox 36,HIGGINS ACT 2615 Telephone (02)62542961 Email [email protected]. au Web www.ffdlr.org.au 17 March, 2006 Dear Mr Curtis rNQUrRy rNTO AlvtPHETAlvtrNEAlilD OTHER SYNTHETIC DRUGS I refer to your l-etter dated 8 December inviting Famil-ies and Friends for Drug Law Reform to provide a submission to the Committee's inquiry into amphetamine and other synthetic drugs and to subsequent telephone conversations between your office and Mr Bush. We are grateful for the generous extensions that your of f j-ce has allowed us. Please find attached a submission that we have prepared. You will- see that reference is made in it to a number of submissions of Families and Friends for Drug Law Reform to varj-ous parliamentary inquiries. In particular our present submission refers to the two submissions we made last year for the Commi-ttee's review of the AustraJ-ian Crime Commission Act 2002. We woul-d be grateful if the Committee would consi-der the present submission in coniunction with those. We woul-d also be grateful for the opportunity to appear before the Committee to expand on aspects of the submission. Vice-President Mr Jonathan Curtis Committee Secretary Parliamentary Joint Committee on the Australian Crime Commission Parl-i-ament House CANBERRA ACT 2600 Associatedwith the AusrnalrAN Dnuc L^q,wRnronu FouxunTroN Families and Friends for Drug Law Reform (ACT) Inc. committed to preventing tragedy that arises from illicit drug use PO Box 36, HIGGINS ACT 2615 Telephone (02) 6254 2961 Email [email protected] Web www.ffdlr.org.au SUBMISSION OF FAMILIES AND FRIENDS FOR DRUG LAW REFORM TO THE INQUIRY BY THE PARLIAMENTARY JOINT COMMITTEE ON THE AUSTRALIAN CRIME COMMISSION INTO AMPHETAMINES AND OTHER SYNTHETIC DRUGS TABLE OF CONTENTS TABLE OF FIGURES __________________________________________________ iii EXECUTIVE SUMMARY________________________________________________ iv I.
    [Show full text]
  • Methamphetamine Continues to Dominate Synthetic Drug Markets ENES
    GLOBAL 20 S MART September UPDATE VOLUME VOLUME Methamphetamine continues to dominate synthetic drug markets ENES Research 2018 GLOBAL SMART UPDATE About the SMART Update Content Synthetic drugs constitute one of the most significant Methamphetamine continues to dominate drug problems worldwide. After cannabis, amphet- synthetic drug markets 3 amine-type stimulants (ATS) are the second most Introduction 3 widely used drugs across the globe, with use levels often exceeding those of heroin and/or cocaine. Along Are the threats of methamphetamine with ATS, the continued growth of the new psychoac- underestimated? 3 tive substances (NPS) market over the last years has Analysing methamphetamine seizures: become a policy challenge and a major international a case study of China and Myanmar 5 concern. A growing interplay between these new drugs Prices along the methamphetamine and traditional illicit drug markets is being observed. trafficking chain 6 By December 2017, the emergence of NPS had been reported by 111 countries and territories. Trends on the The two hubs for methamphetamine: East and synthetic drug market evolve quickly each year. South-East Asia and North America 6 The UNODC Global Synthetics Monitoring: Analyses, Trends in methamphetamine manufacture 7 Reporting and Trends (SMART) Programme enhances Is methamphetamine use growing? 7 the capacity of Member States in priority regions to Diversification of the methamphetamine market 9 generate, manage, analyse, report and use synthetic drug information to design effective policy
    [Show full text]
  • Street Names of Ecstasy-Country Specific
    STREET NAMES OF ECSTASY-COUNTRY SPECIFIC Crystalline Methamphetamine MDMA Precursors used Methamphetamine Tablets Australia Ice, crystal meth, Meth, meth tabs Ecstasy, E, Ephedrine/Pseudo- crystal, shabu pingers ephedrine/ ephedra/Phenyl Acetic Acid Cambodia Ice, ya ba chakk, ya ya ba, ya ma, ma thnam krovee --do-- ma kbai (shake- chakk, ma chakk head drug); (chakk = injectable); some young also ya ba, ya ma, ma people say “ecstasy” China bingdu (ice) bingdu pian, ma yao tou ubin --do-- ku (head-shaking pill) Indonesia shabu XTC --do-- Lao PDR ya ba, ya ma ya-E --do-- Japan shabu, “S”, ice, speed; “X”, ecstasy --do-- anpon (particular to Kyushu region); philopoon (liquid methamphetamine) Malaysia Crystal, syabu, ice Meth Ecstasy --do-- Myanmar ya ma, seik kwya Seik kwya say --do-- say, myin say (head-shaking pill) New Zealand "P", crystal, ice Meth tabs Ecstasy --do-- Philippines shabu, bato, sha, XTC, love drug --do-- siopao Thailand ice ya ba ya-E, ya-Love --do-- Viet Nam shaking pill --do-- OTHER STREET NAMES Adam Ecstasy, Methylenedioxymethamphetamine (MDMA) Batmans Methylenedioxymethamphetamine (MDMA) B-Bombs Amphetamines; MDMA A capsule containing drugs; MDMA Bean (methylenedioxymethamphetamine) Bens Amphetamine; MDMA Bibs MDMA Blue Kisses, Blue Methylenedioxymethamphetamine (MDMA) Lips Bumping up MDMA combined with powder cocaine Candyflipping The combined use of ecstasy and LSD Caps Heroin; psilocybin/psilocin; crack Charity Methylenedioxymethamphetamine Chalk MDMA Chemical Ice MDMA Cloud nine Crack cocaine; MDMA Club Drug MDMA
    [Show full text]
  • DETENTION AS TREATMENT Detention of Methamphetamine Users in Cambodia, Laos, and Thailand
    DETENTION AS TREATMENT Detention of Methamphetamine Users in Cambodia, Laos, and Thailand DETENTION AS TREATMENT Detention of Methamphetamine Users in Cambodia, Laos, and Thailand March 2010 International Harm Reduction Development Program Copyright © 2010 Open Society Institute. All rights reserved. Writing: Nick Thomson Editing: Roxanne Saucier and Daniel Wolfe Copy Editing: Paul Silva and Thomas Bane Layout: Judit Kovács l Createch Ltd. For more information, contact: International Harm Reduction Development Program OSI Public Health Program www.soros.org/health Telephone 1 212 548 0600 Email [email protected] Acknowledgments This report would not have been possible with out the assistance and support of many people working in the Southeast Asian region and indeed outside of the region. I would like thank the people who have shared their experiences of compulsory detention. I would like to thank my colleagues from the field who were instrumental in collecting and analyzing interviews, including Sara Bradford in Cambodia, Khun Non in Thailand and Mr. Gai in Laos. Many individuals working within particular government departments in Thailand, Laos and Cambodia provided information and shared their thoughts on this issue and I am grateful for their assistance. I was given much informal support from various people within UN agencies in the region, particularly WHO in Cambodia. This work would not have been possible without the help of Patrick Duigan and the journalistic and investigative talents of Tom Fawthrop. Professor Chris Beyer from the Center for Public Health and Human Rights at Johns Hopkins School of Public Health provided significant technical advice and also reviewed several drafts as did Katie Sutcliffe from the Department of Epidemiology.
    [Show full text]